BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 5035304)

  • 1. Degeneration of central and peripheral noradrenaline neurons produced by 6-hydroxy-DOPA.
    Sachs C; Jonsson G
    J Neurochem; 1972 Jun; 19(6):1561-75. PubMed ID: 5035304
    [No Abstract]   [Full Text] [Related]  

  • 2. L-dopa in Parkinsonism. A possible mechanism of action.
    Ng LK; Chase TN; Colburn RW; Kopin IJ
    Neurology; 1972 Jul; 22(7):688-96. PubMed ID: 4673250
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of drugs on the 6-hydroxydopamine induced degeneration of adrenergic nerves.
    Jonsson G; Malmfors T; Sachs C
    Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):543-56. PubMed ID: 5034513
    [No Abstract]   [Full Text] [Related]  

  • 4. Noradrenaline uptake mechanisms in the mouse atrium. A biochemical and histochemical study.
    Sachs C
    Acta Physiol Scand Suppl; 1970; 341():1-66. PubMed ID: 5452309
    [No Abstract]   [Full Text] [Related]  

  • 5. 6-Aminodopamine-induced degeneration of catecholamine neurons.
    Jonsson G; Sachs C
    J Neurochem; 1973 Jul; 21(1):117-24. PubMed ID: 4720890
    [No Abstract]   [Full Text] [Related]  

  • 6. Noradrenaline nerve terminals in the cerebral cortex: effects on noradrenaline uptake and storage following axonal lesion with 6-hydroxydopamine.
    Lidbrink P; Jonsson G
    J Neurochem; 1974 May; 22(5):617-26. PubMed ID: 4152079
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of release of alpha-methylated noradrenaline analogues by monoamine oxidase inhibitors.
    Carlsson A; Lindqvist M; Waldeck B
    Eur J Pharmacol; 1968 Apr; 3(1):34-9. PubMed ID: 5654667
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of L-dopa on efflux of cerebral monoamines from synaptosomes.
    Ng KY; Colburn RW; Kopin IJ
    Nature; 1971 Apr; 230(5292):331-2. PubMed ID: 5549411
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
    Ng LK; Colburn RW; Kopin IJ
    J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
    [No Abstract]   [Full Text] [Related]  

  • 10. Failure of 6-hydroxynoradrenaline to produce degeneration of catecholamine neurons.
    Sachs C
    Eur J Pharmacol; 1972 Nov; 20(2):149-55. PubMed ID: 4651204
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of reserpine on release of ( 3 H)noradrenaline, ( 3 H)dopamine and ( 3 H)metaraminol from field stimulated rat iris.
    Farnebo LO
    Biochem Pharmacol; 1971 Oct; 20(10):2715-26. PubMed ID: 5114507
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the action of some psychoactive drugs on central noradrenaline neurons after inhibition of dopamine-beta-hydroxylase.
    Corrodi H; Fuxe K; Ljungdahl A; Ogren SO
    Brain Res; 1970 Dec; 24(3):451-70. PubMed ID: 5494534
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective 6-hydroxy-DOPA induced degeneration of central and peripheral noradrenaline neurons.
    Sachs C; Jonsson G
    Brain Res; 1972 May; 40(2):563-8. PubMed ID: 5027179
    [No Abstract]   [Full Text] [Related]  

  • 14. Actions of 6-hydroxydopamine quinones on catecholamine neurons.
    Jonsson G; Sachs C
    J Neurochem; 1975 Oct; 25(4):509-16. PubMed ID: 1173817
    [No Abstract]   [Full Text] [Related]  

  • 15. Release of norepinephrine from isolated rat iris by field stimulation.
    Farnebo LO; Hamberger B
    J Pharmacol Exp Ther; 1970 Apr; 172(2):332-41. PubMed ID: 5441158
    [No Abstract]   [Full Text] [Related]  

  • 16. Degeneration of central noradrenaline neurons after 6-hydroxydopamine in newborn animals.
    Sachs C; Jonsson G
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):203-20. PubMed ID: 4671892
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on central and peripheral noradrenaline neurons using a new dopamine-(beta)-hydroxylase inhibitor.
    Corrodi H; Fuxe K; Hamberger B; Ljungdahl A
    Eur J Pharmacol; 1970 Oct; 12(2):145-55. PubMed ID: 5472868
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological modifications of the 6-hydroxy-dopa induced degeneration of central noradrenaline neurons.
    Jonsson G; Sachs C
    Biochem Pharmacol; 1973 Jul; 22(14):1709-16. PubMed ID: 4715992
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of 6-hydroxydopa on peripheral adrenergic neurons.
    Kostrzewa R; Jacobowitz D
    J Pharmacol Exp Ther; 1972 Nov; 183(2):284-97. PubMed ID: 5083546
    [No Abstract]   [Full Text] [Related]  

  • 20. L-dopa induced changes in central monoamine neurons after peripheral decarboxylase inhibition.
    Butcher L; Engel J; Fuxe K
    J Pharm Pharmacol; 1970 Apr; 22(4):313-6. PubMed ID: 4392579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.